Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Your search for follwing guidelines returned no results
Showing 1051 to 1100 of 1116 results for following guidelines

  1. Isatuximab in combination for untreated multiple myeloma when a stem cell transplant is unsuitable (TA1098)

    Evidence-based recommendations on isatuximab (Sarclisa) plus bortezomib, lenalidomide and dexamethasone for untreated multiple myeloma in adults when an autologous stem cell transplant is unsuitable.

  2. Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19 (TA878)

    Evidence-based recommendations on nirmatrelvir plus ritonavir (Paxlovid), sotrovimab (Xevudy) and tocilizumab (RoActemra) for treating COVID-19.

  3. Spesolimab for treating generalised pustular psoriasis flares (TA1070)

    Evidence-based recommendations on spesolimab (Spevigo) for treating generalised pustular psoriasis flares in adults.

  4. Leniolisib for treating activated phosphoinositide 3-kinase delta syndrome in people 12 years and over (HST33)

    Evidence-based recommendations on leniolisib (Joenja) for treating activated phosphoinositide 3-kinase delta syndrome in people 12 years and over.

  5. Daridorexant for treating long-term insomnia (TA922)

    Evidence-based recommendations on daridorexant (QUVIVIQ) for treating long-term insomnia in adults.

  6. Tests to help assess risk of acute kidney injury for people being considered for critical care admission (ARCHITECT and Alinity i Urine NGAL assays, BioPorto NGAL test and NephroCheck test) (HTG544)

    Evidence-based recommendations on tests to help assess risk of acute kidney injury for people being considered for critical care admission. The tests are the ARCHITECT and ALINITY i Urine NGAL assays, BioPorto NGAL test and NephroCheck test.

  7. Testing strategies for Lynch syndrome in people with endometrial cancer (HTG557)

    Evidence-based recommendations on testing strategies for Lynch syndrome for people with endometrial cancer.

  8. Prioritising our guidance topics

    Our centralised approach to prioritising our guidance topics ensures that we produce guidance that's relevant, timely, accessible, and has demonstrable impact.

  9. Technology appraisal committee A members

    Biographies and registered interests for members of the Technology Appraisal Committee A

  10. Technology appraisal committee B members

    Find out more about the NICE technology appraisal advisory committee B members and their registered interests

  11. Executive team

    Day-to-day decision making is the responsibility of NICE's executive team.

  12. Modular updates

    Our modular updates framework ensures flexibility and consistency in updating our manuals and helps prioritise important updates.

  13. Accessibility

    NICE wants as many people as possible to be able to use our services, and we have designed it to be accessible.

  14. Public health advisory committees

    The standing committees were responsible for the development of our public health guidance.

  15. How we develop NICE guidelines

    The guidance development timeline

  16. About shared decision making

    Information and benefits about shared decision making. Includes links to patient decision aids.

  17. Using NICE guidance in social work: scenarios

    situations and people They can help social workers understand how to put our guidelines and quality standards into practice. Social care...

  18. Register your organisation as a stakeholder

    Our stakeholders are involved in the development of NICE guidance and quality standards to ensure that the recommendations are relevant, practical, and meet the needs of those affected by the health or social care issues addressed.

  19. Your role as a NICE committee member

    reproductive health guidelines update committee. Bryony discusses the vital role of our committees and why she'd encourage you to get...

  20. How to use quality standards

    How providers and commissioners can use quality standards to improve the quality of care

  21. Terms and conditions

    all information contained in them are available for use subject to the following terms and conditions. By accessing the websites, you...

  22. History of NICE

    Excellence became a legal entity in April. Our aim was to create consistent guidelines and end rationing of treatment by postcode across...

  23. Our principles

    The principles that guide the development of NICE guidance and standards.

  24. Developing community assets

    social workers Scenario A social worker makes a home visit to a family following concerns of neglect highlighted by the school. Katie,...

  25. How we develop technology appraisal guidance

    A step-by-step summary about how we develop our technology appraisal guidance.

  26. Supporting the health and care system to implement virtual wards

    Virtual wards (also known as hospital at home) provide hospital level care at home.

  27. Patient and public involvement policy

    Read NICE's patient and public involvement policy.

  28. Supporting inter-generational need

    blind, has a moderate learning disability and is experiencing depression following the loss of her father. Farzana's mum, Shazia, has...

  29. Developing relationships with parents

    older people Scenario A social worker makes a home visit to a family following concerns of neglect highlighted by the school. Katie, the...

  30. Involving families in care planning

    self-harm. She has recently been admitted to an inpatient mental health unit following an overdose. Chloe lives with her dad, Jakob....

  31. Taking a person-centred approach to rehabilitation

    discussion with the occupational therapist in the stroke rehabilitation team. Following the discussion there is agreement that visiting...

  32. 'Artificial pancreas' transforming the lives of thousands of children and young people with type 1 diabetes

    The innovative hybrid closed loop (HCL) systems offer improved blood sugar control and can transform daily life for families managing this complex condition.

  33. Data collection agreement

    guidance"}}]} Data collection agreement About our guidance About NICE guidelines About technology appraisal guidance What is technology...

  34. Updated guideline to increase access to treatments for early-stage chronic heart failure could reduce deaths and hospital admissions by thousands

    Around 3,000 deaths and 5,500 hospital admissions in England caused by chronic heart failure could be prevented each year following our updated draft guideline on medical treatment of the disease.

  35. Cost saving guidance

    the resource impact of NICE guidance Resource planner Mapping NICE guidelines to the CQC's single assessment framework NICE and health...

  36. Stage 4: treatment, assessment and monitoring

    In virtual wards, people can receive virtual and technology-assisted treatment, assessment, and monitoring.

  37. Stage 3: admission to the system

    In virtual wards, patients remain at home to receive hospital-level care. Our guidance can help you determine if patients are suitable for admission to the virtual wards system.

  38. Stage 2: clinical assessment

    In a virtual ward setting, you make assessments at home to support clinical decision-making. Our guidance can help you give advice by highlighting areas to consider and standards of care.

  39. Stage 5: discharge and transferring care

    Our guidance helps you hand over care and ensure people are safely transitioned out of the virtual ward environment.

  40. New guideline will help cut falls and related hospital admissions for older and at-risk people

    Personalised assessments that consider factors including the hazards in a person’s home, and their previous medical history will help reduce falls in older and at-risk people, according to a new NICE guideline.

  41. Record number of positive recommendations for blood cancer treatments

    Around 5,000 blood cancer patients could benefit from 13 treatments recommended by NICE in 2024.

  42. NICE has made six times more lung cancer treatment recomendations over the past ten years than in the previous decade

    We have also recommended osimertinib for routine use on the NHS today.

  43. NICE describes how weight loss drug tirzepatide will be rolled out

    The medication will initially be offered only to those people with the highest clinical needs.

  44. Multiple long-term conditions: falls prevention advice

    This indicator has been removed following the publication of NICE guideline NG249.

  45. NICE recommends 8 digitally enabled therapies to treat depression and anxiety

    Eight digital enabled therapies to treat depression and anxiety disorders in adults have been conditionally recommended by NICE in draft guidance.

  46. 3 treatments for COVID-19 recommended in draft guidance

    Three treatments for COVID have been recommended in draft NICE guidance released today for public consultation.

  47. Working in partnership to harness the potential of digital technology

    Nicola Bent talks about NICE and the AHSN Network’s important ambition to address market access challenges for digital innovation as part of the collaboration agreement.

  48. NICE sets out further details on menopause guideline update

    NICE has outlined what aspects of menopause care will be updated in upcoming guidance, including areas where more research is needed.

  49. Using our guidance and resources in continuing professional development (CPD)

    Registered social workers must demonstrate the use of evidence and research to inform their practice in order to meet professional standards. This is echoed in Social Work England’s continuing professional development (CPD) standards.

  50. International collaboration

    Pilar Pinilla-Dominguez reveals how NICE, through its international collaborations and partnerships, aims to contribute to improvements in health and care outcomes across the world, bringing learnings and benefits back to NICE, the NHS and the wider UK health and care system.